Literature DB >> 6877368

Tissue and cell type-specific expression of two human c-onc genes.

R Müller, J M Tremblay, E D Adamson, I M Verma.   

Abstract

Cellular genes containing nucleotide sequences homologous to retroviral oncogenes (v-onc) have been identified in the genomes of a variety of species of both the vertebrate and invertebrate phyla. Expression of such genes, termed c-onc genes, has been shown to be tissue-specific in chickens and mice and to be modulated during murine development and differentiation of human haematopoietic cells. We report here that the level of the c-fos gene transcripts is 100-fold greater in human term fetal membranes than in other normal human tissues and cells. These levels of c-fos expression in human amniotic and chorionic cells are close to the level of v-fos expression that results in the induction of osteosarcomas in mice and transformation of fibroblasts in vitro. This observation suggests that the induction of neoplastic transformation by the FBJ murine osteosarcoma virus may require the expression of the fos gene product at high levels in an inappropriate cell type. In contrast, the human c-fms gene is expressed at high levels specifically in term placenta and trophoblastic cells. The tissue and cell type-specific patterns of c-fos and c-fms expression suggest that the physiological function of the c-fos and c-fms encoded proteins may be associated with those embryo-derived cells whose primary functions are protection and nourishment of the human fetus.

Entities:  

Mesh:

Year:  1983        PMID: 6877368     DOI: 10.1038/304454a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  32 in total

1.  Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.

Authors:  J Visvader; I M Verma
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

Review 2.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

3.  Regulation of the human c-myc gene: 5' noncoding sequences do not affect translation.

Authors:  N Z Butnick; C Miyamoto; R Chizzonite; B R Cullen; G Ju; A M Skalka
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

4.  Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development.

Authors:  A Jakobovits; G M Shackleford; H E Varmus; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  Transcriptional and posttranscriptional regulation of CSF-1 gene expression in human monocytes.

Authors:  J Horiguchi; E Sariban; D Kufe
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

6.  Human c-fms proto-oncogene: comparative analysis with an abnormal allele.

Authors:  J S Verbeek; A J Roebroek; A M van den Ouweland; H P Bloemers; W J Van de Ven
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

7.  Light and electron microscopic evidences of the presence of c-fos-like immunoreactivity in the rat adrenal cortex.

Authors:  G Yang; J Koistinaho; S Zhu; A Hervonen
Journal:  Histochemistry       Date:  1989

8.  Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage.

Authors:  Markus Christmann; Maja T Tomicic; Dorthe Aasland; Nicole Berdelle; Bernd Kaina
Journal:  Nucleic Acids Res       Date:  2010-05-28       Impact factor: 16.971

9.  Expression of a fms-related oncogene in carcinogen-induced neoplastic epithelial cells.

Authors:  C Walker; P Nettesheim; J C Barrett; T M Gilmer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells.

Authors:  G L Mutter; D J Wolgemuth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.